Medicare Enrolled
Dr. Dragos Zanchi, M.D
Pulmonary Disease · Brandon, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Zanchi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Zanchi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Zanchi
Dr. Dragos Zanchi is a pulmonary disease specialist in Brandon, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Zanchi performed 8,471 Medicare services across 3,678 unique beneficiaries.
Between the years covered by Open Payments, Dr. Zanchi received a total of $43,850 from 69 pharmaceutical and/or device companies across 981 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Zanchi is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 2% volume in FL
$43,850 industry payments
Medicare Practice Summary
Medicare Utilization ↗8,471
Medicare services
Top 2% in FL for pulmonary disease
3,678
Unique beneficiaries
$44
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~424 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Allergy skin test A diagnostic test performed to identify specific allergies by applying or introducing allergenic extracts to the body. The procedure measures the patient's immune response to various potential allergens. |
2,808 | $3 | $15 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,984 | $93 | $180 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
1,323 | $20 | $64 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
332 | $27 | $113 |
| Breathing device use evaluation An assessment of how a patient uses a breathing device. The provider reviews the patient's technique and device handling. |
332 | $13 | $32 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
329 | $43 | $75 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
299 | $24 | $146 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
294 | $40 | $75 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
176 | $121 | $204 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
98 | $37 | $141 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
93 | $31 | $116 |
| Sleep study in sleep lab (age 6+) An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older. |
73 | $447 | $1,688 |
| Sleep study with continuous airway pressure, age 6+ A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older. |
73 | $471 | $1,800 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
58 | $14 | $55 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
45 | $94 | $176 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
40 | $9 | $41 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing, airflow, and physical effort during sleep. |
39 | $69 | $500 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
33 | $66 | $169 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
25 | $33 | $55 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
17 | $37 | $140 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$43,850
Total received (2018-2024)
Avg $6,264/year across 7 years
Top 7% in FL for pulmonary disease
69
Companies
981
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$27,626 (63.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,975 (36.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$250 (0.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,887
2023
$12,765
2022
$9,170
2021
$9,732
2020
$4,501
2019
$2,296
2018
$2,500
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$18,816
Intuitive Surgical, Inc.
$9,906
GlaxoSmithKline, LLC.
$3,447
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,127
Takeda Pharmaceuticals U.S.A., Inc.
$1,117
Grifols USA, LLC
$620
JAZZ PHARMACEUTICALS INC.
$559
Novartis Pharmaceuticals Corporation
$546
Regeneron Healthcare Solutions, Inc.
$543
Harmony Biosciences LLC
$516
Genentech USA, Inc.
$477
Mylan Specialty L.P.
$432
GENZYME CORPORATION
$395
Eisai Inc.
$394
Amgen Inc.
$352
Philips Electronics North America Corporation
$351
Jazz Pharmaceuticals Inc.
$320
Pharming Healthcare, Inc.
$318
ANI Pharmaceuticals, Inc.
$263
Sunovion Pharmaceuticals Inc.
$235
Insmed, Inc.
$218
Circassia Pharmaceuticals Inc
$210
Bayer HealthCare Pharmaceuticals Inc.
$193
Mallinckrodt Hospital Products Inc.
$184
Electromed, Inc.
$184
Baxter Healthcare
$172
Medical Device Business Services, Inc.
$148
Teva Pharmaceuticals USA, Inc.
$128
United Therapeutics Corporation
$126
Covis Pharma GmBH
$100
Shire North American Group Inc
$96
HARMONY BIOSCIENCES LLC
$95
FUJIFILM Healthcare Americas Corporation
$95
Phadia US Inc.
$91
Advanced Respiratory, Inc
$80
Philips North America LLC
$79
ARBOR PHARMACEUTICALS, INC.
$56
Actelion Pharmaceuticals US, Inc.
$55
Axsome Therapeutics, Inc.
$50
Genentech, Inc.
$47
PFIZER INC.
$43
Paratek Pharmaceuticals, Inc.
$42
Almatica Pharma LLC
$38
Nabriva Therapeutics, plc
$38
ADVANCED RESPIRATORY, INC
$35
Avanir Pharmaceuticals, Inc.
$35
SHIELD THERAPEUTICS INC
$35
Inspire Medical Systems, Inc.
$33
ALK-Abello, Inc
$33
Vapotherm Inc
$32
Ambu Inc.
$31
Merck Sharp & Dohme LLC
$30
Janssen Pharmaceuticals, Inc
$27
Inogen, Inc.
$26
Bayer Healthcare Pharmaceuticals Inc.
$24
Resmed Corp
$20
Arbor Pharmaceuticals, Inc.
$20
Aytu Bioscience, Inc
$19
Mallinckrodt LLC
$17
Hikma Pharmaceuticals USA
$17
IDORSIA PHARMACEUTICALS US INC
$16
OptiNose US, Inc.
$16
Azurity Pharmaceuticals, Inc.
$16
Shionogi Inc
$15
Optinose US, Inc.
$14
Breathe Technologies, Inc.
$13
Gilead Sciences, Inc.
$12
3B Medical, Inc.
$12
INTUITIVE SURGICAL, INC.
$2
Top 3 companies account for 73.4% of total payments
Associated products mentioned in payments ›
(6299) DreamWear · (8744) Trilogy Evo · (8874) InCourage · (8874) inCourage · (AE4) Secretion Management · ACCRUFER · ACTHAR · AIRSENSE · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · Adempas · Aimovig · AirDuo Digihaler · Arikayce · BELSOMRA · BENLYSTA · BREO · BREO ELLIPTA · BREZTRI · BREZTRI AEROSPHERE · BROVANA · CHANTIX · CINQAIR · CUVITRU · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Da Vinci Surgical System · Dayvigo · Esbriet · FARXIGA · FASENRA · FUJIFILM · Fetroja · GLASSIA · Grastek · HORIZANT · HYQVIA · Hillrom - Vest System Model 105 Home Care · Horizant · INSPIRE · ION · ImmunoCAP · InogenOne · JOENJA · LIFE2000 · LINX Reflux Management System · LONHALA MAGNAIR · LUNA · NAPRELAN · NUCALA · NUZYRA · Nuedexta · OFEV · OPSUMIT · ORENITRAM · PURIFIED CORTROPHIN GEL · Perforomist · ProAir Digihaler · Prolastin-C · Prolastin-C Liquid · QUVIVIQ · QVAR · RUCONEST · Ryaltris · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Sunosi · TAGRISSO · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · Trilogy 100 · UTIBRON · UTIBRON NEOHALER · Utibron · VAPOTHERM · Veklury · WAINUA · WAKIX · Wakix · XARELTO · XOLAIR · XYREM · XYWAV · Xenleta · Xhance · Xofluza · Xolair · Xyrem · YUPELRI · Yupelri · ZolpiMist · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (63%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pulmonary disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 7% for pulmonary disease in FL.
Equivalent to $518 per 100 Medicare services performed
Geographic Context
Pulmonary diseases within 10 mi
73
Per 100K population
4.9
County median income
$75,011
Nearest hospital
HCA FLORIDA BRANDON HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Zanchi is a clinical cardiology specialist, with above-average Medicare volume (top 2% in FL), with speaking/promotional industry engagement in the top 7% of FL peers, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Zanchi experienced with allergy skin test?
Based on Medicare claims data, Dr. Zanchi performed 2,808 allergy skin test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Zanchi receive payments from pharmaceutical companies?
Yes. Dr. Zanchi received a total of $43,850 from 69 companies across 981 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Zanchi's costs compare to other pulmonary diseases in Brandon?
Dr. Zanchi's average Medicare payment per service is $44. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Zanchi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Brandon
Browse pulmonary diseases in Brandon ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in FL
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in FL
Which FL pulmonary diseases receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Intuitive Surgical, Inc. Payments to Doctors
See all physicians who received payments from Intuitive Surgical, Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology